JAK2 and non-small cell lung carcinoma: Notably, the JAK2/STAT3 and PI3K/AKT pathways have been demonstrated to be regulated by SOCS5 and SOCS6 in a variety of malignancies, and they are regulated DDP resistance in NSCLC.